Enteral Feeding Formula Global Market Report 2023 – By Product (Standard Formulas, Disease Specific Formulas), By Stage (Adults, Pediatrics), By Application (Oncology, Gastroenterology, Neurology, Diabetes, Critical Care, Other Applications), By End User (Hospitals, Long Term Care Facilities) – Market Size, Trends, And Global Forecast 2023-2032

The antacids drugs refer to the drugs that are used to neutralize stomach acid, and treat acid reflux, heartburn, and indigestion. Antacids are medications that counteract (neutralise) your stomach's acid to ease heartburn and indigestion. They are available without a prescription from pharmacies and stores and come in liquid or chewable tablet form. It includes drug classes such as proton pump inhibitors, H2 antagonists, surgical simulators, and acid neutralizers in the form of tablets, liquid, or powder. The main classes of antacids are proton pump inhibitors, H2 antagonists, acid neutralizers, and pro-motility agents. Proton-pump inhibitors are a type of drug that reduces stomach acid production significantly and for a long time. They accomplish this by blocking the H+/K+ ATPase proton pump in the stomach in an irreversible manner. The different types of formulations include tablets, liquids, powders, and others and are distributed through various channels such as hospital pharmacies, retail pharmacies, and others. The global antacids market is segmented – 1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents 2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels 3) By Formulation Type: Tablet, Liquid, Powder, Other Formulation Types The global antacids market size will grow from $9.19 billion in 2022 to $9.56 billion in 2023 at a compound annual growth rate (CAGR) of 4.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global antacids is expected to grow to $10.65 billion in 2027 at a CAGR of 2.7%. Poor lifestyle choices resulting in a higher prevalence of acidity are an important driver for the growth of the antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of sleep, and irregular dietary habits, which result in an increase in the acidity level of the stomach and lead to gastroesophageal reflux disease. According to the American College of Gastroenterology, around 60 million Americans suffer from gastroesophageal reflux disease. This drives the demand for antacids. Major players in the antacids market are GlaxoSmithKline PLC., Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd., and AstraZeneca PLC, Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd., Takeda Pharmaceutical Company Limited, Abbott Laboratories, and WellSpring Pharm. The side effects related to antacids are a major restraint for the antacids market. Some of the common side effects of antacids include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may also cause side effects such as constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. In addition, antacids when consumed with other acidic drugs might lead to absorption of both the drugs resulting in reduced efficiency of both the drugs. Mouth-melting antacid is an emerging trend in the antacid market. Antacids were available in tablet, liquid, and powder form until now, however, researchers have now come up with mouth-melting antacids which are made up of micro-mouth melting granules that easily melt in the mouth. These granules present in the antacids act in the form of effervescent. An example of a mouth-melting instant relief antacid is Sunpharma's 'Pepmelt', which integrates the effects of herbal constituents present in it with the contemporary mouth-melting technology. The manufacturers of antacids in the USA need to comply with CFR - Code of Federal Regulations Title 21 laid down by the FDA. According to these regulations, an over-the-counter (OTC) antacid product in a form suitable for oral administration is recognized as safe and effective only if it meets the conditions related to active ingredients established by the regulatory body. North America was the largest region in the antacids market in 2022. The Middle East is expected to be the fastest-growing region in the global antacids market share. The regions covered in the global antacids market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the antacids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The antacids market consists of sales of Alka Seltzer, Maalox, Mylanta, Rolaids, Tums, and Pepto-Bismol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The antacids market research report is one of a series of new reports from The Business Research Company that provides antacids market statistics, including antacids industry global market size, regional shares, competitors with an antacids market share, detailed antacids market segments, market trends, and opportunities, and any further data you may need to thrive in the antacids industry. This antacids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The milk substitutes (non-dairy milk) market consists of sales of milk substitutes. This industry includes establishments that produce milk substitutes such as soy milk, almond milk, and rice milk. The milk substitutes (non dairy milk) market covered in this report is segmented by type into soy milk, almond milk, rice milk, and others. It is also segmented by application into food and beverages, by distribution channel into supermarkets, hypermarkets, convenience stores, specialty stores, online retail stores, and others, and by formulation into plain-sweetened, plain-unsweetened, flavored-sweetened, and others. The global milk substitutes (non dairy milk) market is segmented - 1) By Type: Soy Milk, Almond Milk, Rice Milk, Other Types 2) By Application: Food, Beverages 3) By Distribution Channel: Supermarkets, Hypermarkets, Convenience Stores, Specialty Stores, Online Retail Stores, Other Distribution Channels 4) By Formualtion: Plain-Sweetened, Plain-Unsweetened, Flavored-Sweetened, Other Formulations The global milk substitutes (non dairy milk) market size will grow from $30.03 billion in 2022 to $34.27 billion in 2023 at a compound annual growth rate (CAGR) of 14.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of the global milk substitutes (non dairy milk) market is expected to grow to $58.6 billion in 2027 at a CAGR of 14.4%. The increasing consumer's preference for vegan food is driving the milk substitute market. Consumers are increasingly becoming aware of animal abuse at dairy farms and are avoiding animal-based products. Vegan milk is cholesterol-free, rich in vitamin D and proteins and provides more calcium than animal milk. According to a report by Mintel, sales of non-dairy milk in the USA grew 61% over the last five years. The rising shift towards veganism and health consciousness is driving the milk substitute market. Major players in the milk substitutes (non dairy milk) market report are Hain Celestial Group, WhiteWave Foods, ADM, Nutriops S.L and Blue Diamond Growers. The presence of highly toxic arsenic compounds in rice milk is acting as a restraint on the milk substitute market. Rice milk is made from rice that carries huge levels of arsenic, a highly toxic chemical that is dangerous for human health and may cause cancer. According to a journal on food additives and contaminants, the arsenic proportion in rice milk has a mean value of 63%, which is dangerous for human health. Non-dairy milk producing companies are increasingly focusing on improving the shelf life of their products. Companies are trying to decrease the rate of bacterial formation in non-dairy milk through bacterial clarification using separators intended to remove bacterial spores. Ultra-pasteurization involves heating milk to a temperature of more than 280°F for at least 2 seconds that will kill harmful bacteria and increases shelf life to up to 120 days. For instance, soymilk produced by SunOpta is processed using ultra-pasteurization and has an extended shelf life of 12 months. Also, ultra-pasteurized almond milk by Pacific Foods has a shelf life of about a year. Non-dairy milk producers are governed by various regulations related to product quality, labelling, and others. For instance, in the EU, Regulation (EU) No 1169/2011 was introduced to provide nutritional information about food products to consumers. According to the regulation, non-dairy milk producing companies have to adhere to different protocols pertaining to nutritional labelling, presentation, advertising of foodstuffs and the printed information must be of a minimum font size. The allergens (e.g. soy, nuts, gluten, and lactose) for prepacked foods should be clearly mentioned. For non-dairy products like milk substitutes, an indication of substitute ingredient should be clearly mentioned. North America was the largest region in the milk substitutes (non dairy milk) market in 2022. Western Europe was the second largest region in the global milk substitutes (non dairy milk) market share. The regions covered in the milk substitutes (non dairy milk) market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the milk substitutes (non dairy milk) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The milk substitutes (non-dairy milk) market consists of sales of soy milk, nut milk, oat milk, rice milk. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The milk substitutes (non dairy milk) market research report is one of a series of new reports from The Business Research Company that provides milk substitutes (non dairy milk) market statistics, including milk substitutes (non dairy milk) industry global market size, regional shares, competitors with milk substitutes (non dairy milk) market share, detailed milk substitutes (non dairy milk) market segments, market trends and opportunities, and any further data you may need to thrive in the milk substitutes (non dairy milk) industry. This milk substitutes (non-dairy milk) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Pharmaceutical contract development and manufacturing refers to a business that offers services for drug research and manufacture within the pharmaceutical sector. Using CDMOs as a partner, pharmaceutical companies can outsource medication development and production. Full-service drug development and manufacturing outsourcing companies (CDMOs) can handle every stage of the process and work with clients that want to outsource specific steps in their workflow. Everything is based on the requirements of each client. The main types of pharmaceutical contract development and manufacturing organisations (CMO) are active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development and manufacturing, and secondary packaging. The active pharmaceutical ingredient (API) manufacturing includes the manufacturing of the part of any drug that produces the desired effects. The various research phases include preclinical, phase I, phase II, phase III, and phase IV. The different end-use sectors include big pharmaceutical companies, generic pharmaceutical companies, and small & medium-sized pharmaceutical companies. The global pharmaceutical contract development and manufacturing organisation (CMO) market is segmented - 1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging 2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV 3) By End-User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies The global pharmaceutical contract development and manufacturing market grew from $122.31 billion in 2022 to $130.82 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical contract development and manufacturing market is expected to grow from $196.53 billion in 2027 at a CAGR of 10.7%. The growth of the pharmaceutical contract development and manufacturing market is driven by the increase in the demand for medicines across the globe. The high prevalence of diseases and the need for a longer lifespan increased the demand for medicines pushing the pharmaceutical companies to increase the production of existing drugs and raise the investment in their R&D to promote the development of new drugs. This impels the pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to lower operational costs, thus, increasing the demand for pharmaceutical contract development and manufacturing market. According to Alkermes PLC., a biopharmaceutical company indicates that pharmaceutical contract manufacturing will emerge as a strategic option for many companies ranging from very large to smaller specialty pharma entities and this mostly will happen because the pharmaceuticals companies are looking for cost-cutting. Major players in the pharmaceutical contract development and manufacturing market are Recipharm AB, Pfizer Inc., Boehringer Ingelheim International GmbH, Aenova Group, Famar, Jubilant Life Sciences Limited, Catalent Pharma Solutions, Chemicals Limited, Dishman Pharmaceuticals, HAUPT Pharma AG, Kemwell Pvt. Ltd., Nipro Corp., NextPharma, Royal DSM N.V., Althea Technologies, Thermo Fisher Scientific Inc., Lonza Group Ltd., AbbVie Inc., Consort Medical PLC., Almac Group, Siegfried Holding AG, Evonik Industries AG, and Vetter Pharma International GMBH. The pharmaceutical contract development and manufacturing market are restricted by the poor-capacity utilization of manufacturing facilities. The capacity utilization is calculated considering the full potential capacity of the production plant. The poor-capacity utilization of the production plant is caused due to the inefficiency of different sub-processes in the production line which results in low production. The low production output results in low revenue generation for the production unit, affecting the overall pharmaceutical contract development and manufacturing market. For instance, in January 2020, according to an article shared by Economic Times, an India-based English-language business-focused daily newspaper, The 1,500 API manufacturing facilities in India, according to the country's drug regulatory organisation, are only operating at 40% of their potential. Therefore, the usage of capacity of the production plant negatively affects the pharmaceutical contract development and manufacturing market. The companies in the pharmaceutical contract development and manufacturing market are investing in acquiring and forming alliances with other companies in the market. The pharmaceutical contract development and manufacturing companies are following the trend of merger and acquisition to expand their global market reach to meet the client needs, increase their production capabilities while maintaining cost efficiencies, and get access to the latest technology and new services. The high levels of merger and acquisition activities are resulting in the consolidation of the contract service providers. For instance, in July 2022, Pharma Nobis, a US-based provider of contract manufacturing and private label services, acquired Fagron’s U.S. contract manufacturing business for an undisclosed amount. Through this acquisition, Pharma Nobis is expected to offer contract manufacturing and private label services to American retailers and consumer healthcare corporations. 20% of the company will continue to be owned by Fagron. In August 2022, Catalent, Inc., a US-based provider of delivery technologies, development, and drug manufacturing, acquired Metrics Contract Services for $475 million. This acquisition is expected to improve Catalent's ability to work with highly potent chemicals while enhancing its expertise in integrated oral solid formulation research, production, and packaging to assist clients in streamlining and accelerating their processes. Metrics Contract Services is a US-based pharmaceutical contract development and manufacturing organization. North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2022. The Middle East is expected to be the fastest growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the global pharmaceutical contract development and manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical contract development and manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceutical contract development and manufacturing market includes revenues earned by entities by providing drug development and manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The pharmaceutical contract development and manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing market statistics, including pharmaceutical contract development and manufacturing industry global market size, regional shares, competitors' pharmaceutical contract development and manufacturing market share, detailed pharmaceutical contract development and manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing industry. This pharmaceutical contract development and manufacturing market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharmaceutical excipients refer to components of a drug delivery system that are not active pharmaceutical ingredients (API) but have undergone acceptable safety evaluation. Excipients, which are not active themselves, allow the drug ingredient to be administered to the patient in the proper form and support the mode and site of action. The main types of products in pharmaceutical excipients are inorganic chemicals and organic chemicals. The pharmaceutical inorganic chemical industry is concerned with the manufacture, physical or chemical characteristics of substances, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. The different functionalities include fillers and diluents, suspending and viscosity agents, coating agents, bindeflavoringring agents sweetenersners, disintegrants, colorants, lubric, ants, and glidants, and others and involve various formulations such as oral formulation, topical formulation, and parental formulation. The global pharmaceutical excipients market is segmented - 1) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavouring Agents And Sweetners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities 2) By Type Of Formulation: Oral Fromulation, Topical Formulation, Parental Formulation 3) By Product: Inorganic Chemicals, Organic Chemicals The global pharmaceutical excipients market size grew from $8.6 billion in 2022 to $9.11 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global pharmaceutical excipients is expected to grow from $11.55 billion in 2027 at a CAGR of 6.1%. The global surge in the sale of generic drugs contributed to the growth of the pharmaceutical excipients market. Generic drugs are alternatives to the marketed brand-name drug in the same dosage form, safety, strength, route of administration, and quality. According to India Brand Equity Foundation (IBEF), India is the largest provider of generic medicines, the country’s generic drugs account for 20% of the global generic drug exports. Indian pharmaceutical companies received 300 generic drug approvals in the USA. The surge in the demand for generic drugs drives the pharmaceutical excipients market. Major players in the pharmaceutical excipients market report are Archer Daniels Midland Co., Associated British Foods, Dow Chemical Company, Evonik, Croda International PLC., Ashland, BASF SE, The Lubrizol Corporation, and Roquette Frères. Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market. According to the Pharmaceutical Journal, there are certain complications in children with the use of pharmaceutical drugs with excipients. For instance, the colourants used in medicine as colouring agents may lead to sensitivity reactions and hyperactive behaviour in children. Ethanol is another solvent that is widely used in an oral liquid formulation, the use of ethanol mixed medicine for children may have a risk of acute intoxication when overdose, and it may lead to chronic toxicity with long-term use. Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market. The increase in research and development in pharmaceutical formulation to enhance the production process and product quality by using multi-functional excipients is a trend shaping the market. Excipients play a significant role in helping pharmaceutical manufacturers better support patients by increasing compliance and treatment effectiveness. For instance, Evonik’s newly launched EUDRAGIT FS 100 is a solid version of the existing EUDRAGIT FS 30 D. This new multi-functional version allows pharmaceutical companies to use the polymer in many new applications, such as hot-melt extrusion, solvent spray-drying, and solvent coating, which was impossible to achieve in past decades where only the aqueous version was available. In July 2021, Philip Morris International, a US-based cigarette and tobacco manufacturing company acquired Fertin Pharma for $820m. Through this acquisition, PMI will gain significant ability in developing, formulating, and marketing existing as well as new smoke-free platforms. Fertin Pharma is a Denmark-based company that manufactures pharmaceutical excipients. North America is the largest region in the pharmaceutical excipients market in 2022. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are "factory gate values," that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Fructose is a monosaccharide that occurs in fruits, vegetables, honey, and some plants. The fructose industry includes establishments that derive fructose from various raw materials, such as sugarcane, sugar beet, and corn that are used in the food and beverage industry in the form of sweeteners due to their high relative sweetness and low cost. Fructose is available in both pure crystalline form and as a component of syrups. The main types of products in fructose are high fructose corn syrup, fructose syrups, and fructose solids. High fructose corn syrup is a type of fructose derived from corn starch and potatoes with a 40-55% composition of fructose. Fructose is produced from sugarcane, sugar beet, corn, fruits, and vegetables and is used in various applications such as dairy products, baked goods, beverages, cosmetics and personal care, sports nutrition, drug formulations, and others. The global fructose market is segmented - 1) By Product: High Fructose Corn Syrup, Fructose Syrups, Fructose Solids 2) By Source: Sugarcane, Sugar Beet, Corn, Fruits And Vegetables 3) By Application: Dairy Products, Baked Goods, Beverages, Cosmetics And Personal Care, Sports Nutrition, Drug Formulations, Other Applications The global fructose market size grew from $5.32 billion in 2022 to $5.71 billion in 2023 at a compound annual growth rate (CAGR) of 7.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The fructose market size is expected to grow to $7.27 billion in 2027 at a CAGR of 6.2%. The increasing demand for low-sugar and low-calorie food items is contributing to the growth of the fructose market. More individuals are opting for low-sugar, low-calorie foods since they are an excellent way to lose weight while also providing a rich source of vitamins and minerals that are beneficial to one's overall health. As fructose is sweeter than sugar, it can be used to sweeten foods and beverages in smaller amounts. When employed in proper product formulations, this aids in the reduction of calories in foods and beverages, as well as the reduction of future excitation from eating. For instance, according to a survey conducted in 2020 by Archer Daniels Midland (ADM), a US-based food processing company, 67% of customers are concerned about sugars and sweeteners, with 39% indicating that lower sugar is essential to them when it comes to convenience foods, drinks, and snacks. Therefore, the increasing demand for low sugars and low calories is expected to drive the growth of the fructose market in the coming years. Major players in the fructose market are Archer Daniels Midland Company, Atlantic Chemicals Trading, Cargill Corporation, DuPont Nutrition & Biosciences, Galam Ltd., Global Sweeteners Holdings, Ingredion Incorporated, Roquette Freres, Shijiazhuang Huaxu Pharmaceutical Co. Ltd., Showa Sangyo Co. Ltd., The Agrana Group, Ajinomoto Co. Inc., COFCO Rongshi Biotechnology Co. Ltd., Japan Corn Starch Co. Ltd., Kerry Group, Navarest, and NOW Foods. The development of innovative design tools is shaping the fructose market. Major companies operating in the fructose sector are focused on developing innovative tools to strengthen their position. For instance, in July 2020, Tate & Lyle PLC, a UK-based food and beverage ingredients provider launched Sweetener Vantage Expert Systems. It is a set of new and unique sweetener solution design tools developed to assist formulators in creating sugar-free foods and beverages utilizing low-calorie sweeteners. Sweetener Vantage Expert Systems were created in response to client demand for additional predictive tools to boost production efficiency and decrease development time. They will help formulators handle their formulation difficulties more effectively. In July 2021, KPS Capital Partners, a US-based investment company acquired Tate & Lyle for $1.3 billion. Under this agreement, Tate & Lyle and KPS Capital Partners will each control 50% of a newly formed firm. The newly formed business will concentrate on the production of plant-based products for the food and industrial markets. Tate & Lyle is a UK-based company that produces sweeteners and food and beverage ingredients. North America was the largest region in the fructose market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fructose market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the fructose market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The fructose market consists of sales of fructose solids, high fructose corn syrup, and fructose syrups. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The fructose market research report is one of a series of new reports from The Business Research Company that provides fructose market statistics, including fructose industry global market size, regional shares, competitors with a fructose market share, detailed fructose market segments, market trends and opportunities, and any further data you may need to thrive in the fructose industry. This fructose market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dairy ingredients refer to a substance that is used to make dairy goods or serves as a source of ingredients for products made with milk. It contains milk, yoghurt, cheese, lactose-free milk, and yoghurt and fortified soy milk. It excludes dairy products with high fat and low calcium content including cream cheese, sour cream, cream, and butter. The main types of dairy ingredients include milk powder, whey protein, milk protein, third-generation ingredients, casein, buttermilk powder, whey permeate, and lactose. Milk powder is turned into a dry substance by evaporating its water content. Whole milk powder must contain between 26% and 40% milk fat and not more than 5% moisture on a milk solids-not fat basis. The different dairy ingredient sources include milk and whey. The dairy ingredients include powder and liquid. The dairy ingredients production methods include traditional methods and membrane separation, which are used for applications in dairy products, convenience foods, bakery and confectionery, instant milk formula, clinical and sports nutrition, and other applications. The global dairy ingredients market is segmented – 1) By Type: Milk Powder, Whey Protein, Milk Protein, Third- Generation Ingredient, Casein, Butter Milk Powder, Whey Permeate, Lactose 2) By Source: Milk, Whey 3) By Form: Powder, Liquid 4) By Production Method: Traditional Method, Membrane Separation 5) By Application: Dairy Products, Convenience Food, Bakery And Confectionery, Infant Milk Formula, Clinical And Sports Nutrition, Other Applications The global dairy ingredients market size will grow from $64.17 billion in 2022 to $68.4 billion in 2023 at a compound annual growth rate (CAGR) of 6.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global dairy ingredients is expected to grow to $89.69 billion in 2027 at a CAGR of 7.0%. The rise in health concerns among people is contributing to the growth of the dairy ingredients market. Health-conscious individuals are increasing their intake of health products, including dietary products, to maintain a healthy lifestyle. According to the International Food Information Council's (IFIC) 2020 food and health survey, Americans have a strong interest in becoming more health-conscious, with 43% following a specific diet or eating pattern in 2020, up 38% from 2019. Also, 54% of all consumers cared more about the healthfulness of their food and beverage choices in 2020 than they did in 2010. The rise in health concerns will drive the growth of the dairy ingredients market. Major players in the dairy ingredients market are Fonterra Cooperative Group, Royal FrieslandCampina N.V, Arla Foods, Dairy Farmers of America Inc., Agropur Cooperative, Yili China, Saputo Inc., Glanbia PLC, Kerry Group, Prolactal, Hoogwegt Group, Euroserum, Devondale Murray Goulburn, Volac International Limited, Aurivo Co-operative Society Ltd., Dairy Ingredients Inc., Mengniu Dairy Co., Ltd., Megmilk Snow Brand Co., Ltd., Kraft Heinz Company, Morinaga Milk Co., Ltd., Sodiaal International, Nestle S.A, Lactalis Group, Savencia S.A, Ornua, Batory Foods, Ingredia SA, Valio, Hatsun Agro Products, Amul. Automation in the dairy industry is a key trend gaining popularity in the dairy ingredients market. Automation within the dairy industry is a complete integrated dairy plant system. Automation in the dairy industry's manufacturing creates robotic systems which improve production control while increasing capacity. For instance, Swedish automation company ABB offers automation solutions for milk reception, pasteurization, and monitoring and control while transferring milk, cream, and butter milk from reception tanks to packaging machines. The automation systems offer better filtration, automatic de-clogging, high and medium pressure cleaning with multiple repetitions, while reducing loss of milk and limiting the need for cleaning agents. In October 2021, Royal DSM, a Netherlands-based company in the fields of health and nutrition, acquired First Choice Ingredients for an amount of USD453 million. With this acquisition, DSM is expected to further boost the growth of First Choice Ingredients by making their products available to DSM's large international customer base outside of the US and incorporating their solutions into DSM's full offering on taste, texture, and health in sustainable solutions for Food & Beverage customers. First Choice Ingredients is a US-based manufacturer of concentrated dairy flavours. Asia-Pacific was the largest region in the dairy ingredients market in 2022. North America was the second largest market in dairy ingredients market in 2022. The regions covered in the dairy ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the dairy ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The dairy ingredients market consists of sales of butter, cheese, ice cream, yogurt, and condensed and dried milk. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dairy ingredients market research report is one of a series of new reports from The Business Research Company that provides dairy ingredients market statistics, including dairy ingredients industry global market size, regional shares, competitors with a dairy ingredients market share, detailed dairy ingredients market segments, market trends and opportunities, and any further data you may need to thrive in the dairy ingredients industry. This dairy ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The baby food refer to the food products consumed by kids and infants. Baby food is any smooth, easily swallowed food that is created specifically for infants between the ages of four to six months and two years. The main types of baby food are milk formula, dried baby food, ready-to-feed baby food, and other types. Milk formula is a synthetic alternative to breast milk that is used to feed babies. It can be purchased as a powder to be blended with water or as an instant liquid. They are of various categories such as organic, and conventional. Baby foods are based on various distribution channels such as hypermarkets, supermarkets, drug stores, specialty stores, and online. The global baby food market is segmented - 1) By Type: Milk Formula, Dried Baby Food, Ready to Feed Baby Food, Other Types 2) By Category: Organic, Conventional 3) By Distribution Channel: Hypermarkets, Supermarkets, Drug Stores, Specialty Stores, Online The global baby food market size grew from $46.37 billion in 2022 to $49.52 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size baby food is expected to grow to $63.87 billion in 2027 at a CAGR of 6.6%. The increasing working women population is significantly driving the growth of the baby food market. The working women depend highly on baby food to keep their babies with proper nutrition as they cannot spend more time at home, leading to an increase in the demand for baby food.For instance, in September 2022, according to Bureau of Labor Statistics, a US-based government agency, the number of employed women (16 year and above) in September 2021 was 72295000 which increased to 74349000 in September 2022. Hence, the growing working women population is expected to drive the growth of the baby food market in the coming years. Major players in the baby food market are Abbott Nutrition, Bellamy Organics, Danone, Hero-Group, Mead Johnson, Nestle, Perrigo Company, Royal FrieslandCampina N.V., Hain Celestial, Reckitt Benckiser Group plc, Kraft Heinz Company, Campbell soups, Yili, Bristol-Myers Squibb Company, DMK Group, Heinz, and Inner Mongolia Yili Industrial Group Co Ltd. Vegan-based baby food is the key trend in the baby food market. The vegan-based baby food is considered nutritious and safe for babies. The key players in the baby food market are focusing on launching vegan-based baby food products. For instance, in February 2022, Tiny Organics, a firm focused on early childhood nutrition and based in the United States, launched a line of plant-based finger snacks aimed at encouraging youngsters to try new foods. Baby-led weaning (BLW) encourages young children to feed themselves at their speed, and the Tiny Beginnings range is the first non-puree baby food produced for BLW. For babies aged 4 to 8 months, the new range includes six vegetable-forward meal options with a variety of textures and easy-to-grasp sizes. Tiny's meals are 100% organic, include no added sugar or salt, and are designed to suit the nutritional needs of young children. In January 2021, Hero Group, a consumer food manufacturer based in Switzerland has acquired Baby Gourmet for an undisclosed amount. As a result of this acquisition, Hero Group plans to expand its category presence, and the acquisition will reportedly provide the company with a new platform to enter the Canadian infant food market with an organic product line. Baby Gourmet is a Canadian-based company that produces organic meals and snacks for babies. Asia-Pacific was the largest region in the baby food market in 2022 and is expected to be the fastest-growing region in the forecast period. The regions covered in the baby food market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the baby food market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The baby food market consists of sales of cereals, juice, and purees made from fruit, vegetable, cereal. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The baby food market research report is one of a series of new reports from The Business Research Company that provides baby food market statistics, including baby food industry global market size, regional shares, competitors with a baby food market share, detailed baby food market segments, market trends and opportunities, and any further data you may need to thrive in the baby food industry. This baby food market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Probiotics dietary supplement refer to the live microorganisms when consumed in adequate amounts, confer a health benefit on the host. Probiotics dietary supplements are used to balance the friendly bacteria in the digestive system, help in preventing and treating diarrhea, and also improve some mental health conditions in humans. Probiotics dietary supplements are available in the form of capsules, powders, liquids, and other forms, with a wide range of strains and doses. Rather than single strains, they frequently contain mixed cultures of live microorganisms. The main sources of probiotics dietary supplements are yeast and bacteria. The yeast probiotics dietary supplements are used as dietary supplements as it contains high contents of vitamin B, proteins, amino acids, peptides, and trace minerals. The various forms are capsules, chewable and gummies, powders, tablets and soft gels, among others. The products are distributed through business-to-business, and business-to-consumer channels. The different applications are infant formula, food supplements, specialty nutrients, nutritional supplements that are used as human probiotics, and animal probiotics. The global probiotics dietary supplements market is segmented - 1) By Source: Yeast, Bacteria 2) By Form: Capsules, Chewables And Gummies, Powders, Tablets And Softgels, Other Forms 3) By Distribution Channel: Business To Business, Business To Consumer 4) By Application: Infant Formula, Food Supplement, Specialty Nutrients, Nutritional Supplements 5) By End Use: Human Probiotics, Animal Probiotics The global probiotics dietary supplements market size grew from $6.4 billion in 2022 to $6.89 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the probiotics dietary supplements market is expected to grow to $9.44 billion in 2027 at a CAGR of 8.2%. The prevalence of digestive disorders is expected to propel the growth of the probiotic dietary supplements market. Digestive disorder refers to any health problem that occurs in the digestive tract. Increasing incidences of digestive disorders are due to poor nutrition, an unbalanced diet, and lifestyle change. The probiotic supplements help in curing digestive diseases like intestinal inflammation, urogenital infections, and antibiotic-associated diarrhea by fighting against bad bacteria along with good bacteria in humans' intestines. According to the National Institute of Diabetes and Digestive and Kidney Disease, around 60 to 70 million people are affected by all digestive diseases in the USA in 2020. According to a survey on digestive health' of Indian families by ITC in 2021, about 56% of Indian families have reported digestive health issues. The prevalence of digestive disorders globally supports the growth of the probiotics dietary supplement market. Major players in the probiotics dietary supplement market are Probi, Vitakem Nutraceutical Inc., Chr. Hansen Holding A/S, ProbioFerm, Probium, UAS Laboratories, BioGaia, Contract NUTRA, Custom Probiotics Inc., Mercola Probiotics, Nebraska Cultures, Nutraceutix, NutraScience Labs, Winclove BV, and Bayer AG. Strategic partnerships are shaping the probiotic dietary supplements market. The companies operating in the probiotics dietary supplements market are collaborating on the development of advanced dietary supplements. For instance, in June 2021, Kaged Muscle, a US-based sports nutrition company collaborated with Lonza Group AG, a Switzerland-based pharmaceutical manufacturing company to develop Lonza's new probiotic ingredient in the US market named TWK10, which is expected to increase exercise endurance by up to 75%. Addtionallly, In June 2021, a Swedish company Probi partnered with Oriflame, Swiss multi-level marketing to introduce probiotic supplements across the world in the health segment. In November 2021, ADM, a US-based nutrition and agricultural origination and processing company acquired Deerland Probiotics & Enzymes, Inc., for an undisclosed amount. With this deal, ADM aims to power its growth and strengthen its innovation leadership in dietary supplements and functional foods and serve customers around the world. Deerland Probiotics & Enzymes, Inc., is a US-based provider of dietary supplements that use probiotics, prebiotics, and enzyme technology. North America was the largest region in the probiotics dietary supplements market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the probiotics dietary supplement market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the probiotics dietary supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The probiotics dietary supplement market consists of sales of kefir, kimchi, kombucha, miso, sauerkraut, sourdough bread, tempeh and yogurt. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The probiotics dietary supplements market research report is one of a series of new reports from The Business Research Company that provides probiotics dietary supplements market statistics, including probiotics dietary supplements industry global market size, regional shares, competitors with a probiotics dietary supplements market share, detailed probiotics dietary supplements market segments, market trends and opportunities, and any further data you may need to thrive in the probiotics dietary supplements industry. This probiotics dietary supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.